EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular complexity of intraductal carcinoma of the prostate

Sha Zhu iD, Nanwei Xu, Hao Zeng iD

Cancer Medicine · 2024-01 · 13 (2)

DOI: 10.1002/cam4.6939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 20.02.2024. Verfasst von Sha Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical and Translational Medicine Research Project, Chinese Academy of Medical Sciences, Science and Technology Support Program of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraductal carcinoma of the prostate (IDC‐P) is an aggressive subtype of prostate cancer characterized by the growth of tumor cells within the prostate ducts. It is often found alongside invasive carcinoma and is associated with poor prognosis. Understanding the molecular mechanisms driving IDC‐P is crucial for improved diagnosis, prognosis, and treatment strategies. This review summarizes the molecular characteristics of IDC‐P and their prognostic indications, comparing them to conventional prostate acinar adenocarcinoma, to gain insights into its unique behavior and identify potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Intraductal, NoninfiltratingProstatic NeoplasmsMaleHumansProstatePrognosis

Stichwörter der Autor:innen

DNA damage and repairIntraductal carcinoma of the prostateMED12MYCNCOR2PTENRB1SChLAP1TMPRSS2-ERG fusionTP53molecular characteristicsprostate acinar adenocarcinomatargeted therapy

Autor:innen und Institutionen

  • Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Sha Zhu, Hao Zeng

Förderung

  • National Natural Science Foundation of China
  • Clinical and Translational Medicine Research Project, Chinese Academy of Medical Sciences
  • Science and Technology Support Program of Sichuan Province
  • Bethune Foundation, Oncology Basic Research Program
  • West China Hospital, Sichuan University
  • Bethune Foundation, Urological Oncology Special Research Fund

Zitieren

APA

Zhu, S., Xu, N., & Zeng, H. (2024). Molecular complexity of intraductal carcinoma of the prostate. Cancer Medicine, 13(2). https://doi.org/10.1002/cam4.6939

Vancouver

Zhu S, Xu N, Zeng H. Molecular complexity of intraductal carcinoma of the prostate. Cancer Medicine. 2024;13(2). doi:10.1002/cam4.6939

BibTeX
@article{Zhu2024,
  author = {Zhu, Sha and Xu, Nanwei and Zeng, Hao},
  title = {Molecular complexity of intraductal carcinoma of the prostate},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {2},
  doi = {10.1002/cam4.6939}
}
Kostenlos starten →